A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this research are to demonstrate the following:1. To demonstrate
improvement in hair growth and hair appearance following 12 weeks of once daily treatment
with tazarotene/halobetasol lotion in patients with moderate to severe scalp psoriasis.2. To
demonstrate improvement in scalp itch reduction following 12 weeks of once daily treatment
with tazarotene/halobetasol lotion in patients with moderate to severe scalp psoriasis.3. To
pictorially demonstrate improvement in moderate to severe scalp psoriasis with 12 weeks of
once daily treatment with tazarotene/halobetasol lotion.4. To assessment patient perceptions
of the value of a lotion in the treatment of moderate to severe scalp psoriasis.